Reassembly of Nucleosomes at the MLH1 Promoter Initiates Resilencing Following Decitabine Exposure

PLoS Genetics

Volumn 9, Issue 7, 2013, Pages

  Hesson, Luke B ^a   Patil, Vibha ^a   Sloane, Mathew A ^a   Nunez, Andrea C ^a   Liu, Jia ^a   Pimanda, John E ^a   Ward, Robyn L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; PROTEIN MLH1;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; DEMETHYLATION; DNA DEMETHYLATION; DRUG EXPOSURE; DRUG MECHANISM; DRUG RESISTANCE; GENE EXPRESSION; GENE REACTIVATION; GENE RESILENCING; GENE SILENCING; GENETIC ANALYSIS; GENETIC PARAMETERS; GENETIC STABILITY; MLH1 GENE; NUCLEOSOME; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AZACITIDINE; CELL LINE, TUMOR; CHROMATIN ASSEMBLY AND DISASSEMBLY; CPG ISLANDS; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NUCLEAR PROTEINS; NUCLEOSOMES; PROMOTER REGIONS, GENETIC;

EID: 84880831790     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003636     Document Type: Article

References (27)

1. Cowan LA, Talwar S, Yang AS, (2010) Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors. Epigenomics 2: 71-86.
2. Hackanson B, Robbel C, Wijermans P, Lubbert M, (2005) In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies. Ann Hematol 84 Suppl 1: 32-38.
3. Goodyear O, Agathanggelou A, Novitzky-Basso I, Siddique S, McSkeane T, et al. (2010) Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia. Blood 116: 1908-1918.
4. Daskalakis M, Nguyen TT, Nguyen C, Guldberg P, Kohler G, et al. (2002) Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100: 2957-2964.
5. Blum W, Klisovic RB, Hackanson B, Liu Z, Liu S, et al. (2007) Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia. J Clin Oncol 25: 3884-3891.
6. Tsai HC, Li H, Van Neste L, Cai Y, Robert C, et al. (2012) Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 21: 430-446.
7. Prebet T, Gore SD, Esterni B, Gardin C, Itzykson R, et al. (2011) Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure. J Clin Oncol 29: 3322-3327.
8. Qin T, Jelinek J, Si J, Shu J, Issa JP, (2009) Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines. Blood 113: 659-667.
9. Qin T, Castoro R, El Ahdab S, Jelinek J, Wang X, et al. (2011) Mechanisms of resistance to decitabine in the myelodysplastic syndrome. PLoS One 6: e23372.
10. Kagey JD, Kapoor-Vazirani P, McCabe MT, Powell DR, Vertino PM, (2010) Long-term stability of demethylation after transient exposure to 5-aza-2′-deoxycytidine correlates with sustained RNA polymerase II occupancy. Mol Cancer Res 8: 1048-1059.
11. Wong CM, Wong CC, Ng YL, Au SL, Ko FC, et al. (2011) Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recovery. PLoS One 6: e16702.
12. Egger G, Aparicio AM, Escobar SG, Jones PA, (2007) Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2′-deoxycytidine treatment. Cancer Res 67: 346-353.
13. Si J, Boumber YA, Shu J, Qin T, Ahmed S, et al. (2010) Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res 70: 6968-6977.
14. Lin JC, Jeong S, Liang G, Takai D, Fatemi M, et al. (2007) Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 12: 432-444.
15. Deng G, Chen A, Hong J, Chae HS, Kim YS, (1999) Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 59: 2029-2033.
16. Kolodner RD, (1995) Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem Sci 20: 397-401.
17. Hitchins MP, Rapkins RW, Kwok CT, Srivastava S, Wong JJ, et al. (2011) Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5′UTR. Cancer Cell 20: 200-213.
18. You JS, Kelly TK, De Carvalho DD, Taberlay PC, Liang G, et al. (2011) OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proc Natl Acad Sci U S A 108: 14497-14502.
19. Vermeulen M, Mulder KW, Denissov S, Pijnappel WW, van Schaik FM, et al. (2007) Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 131: 58-69.
20. Ooi SK, Qiu C, Bernstein E, Li K, Jia D, et al. (2007) DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448: 714-717.
21. Rodriguez J, Munoz M, Vives L, Frangou CG, Groudine M, et al. (2008) Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc Natl Acad Sci U S A 105: 19809-19814.
22. Takeshima H, Yamashita S, Shimazu T, Niwa T, Ushijima T, (2009) The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res 19: 1974-1982.
23. Goel A, Nguyen TP, Leung HC, Nagasaka T, Rhees J, et al. (2011) De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one. Int J Cancer 128: 869-878.
24. Quinlivan EP, Gregory JF 3rd, (2008) DNA methylation determination by liquid chromatography-tandem mass spectrometry using novel biosynthetic [U-15N]deoxycytidine and [U-15N]methyldeoxycytidine internal standards. Nucleic Acids Res 36: e119.
25. Liu J, Hesson LB, Meagher AP, Bourke MJ, Hawkins NJ, et al. (2012) Relative distribution of folate species is associated with global DNA methylation in human colorectal mucosa. Cancer Prev Res (Phila) 5: 921-929.
26. Regha K, Sloane MA, Huang R, Pauler FM, Warczok KE, et al. (2007) Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome. Mol Cell 27: 353-366.
27. Kelly TK, Miranda TB, Liang G, Berman BP, Lin JC, et al. (2010) H2A.Z maintenance during mitosis reveals nucleosome shifting on mitotically silenced genes. Mol Cell 39: 901-911.